Imprint Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.9K Sell
88
-18
-17% -$18.2K 0.37% 47
2025
Q4
$114K Sell
106
-80
-43% -$76.5K 0.53% 37
2025
Q3
$142K Buy
+186
New +$138K 0.45% 46
2024
Q1
$3.25M Buy
4,276
+2,901
+211% +$2.06M 0.79% 30
2023
Q4
$808K Sell
1,375
-1,349
-50% -$787K 0.65% 46
2023
Q3
$1.46M Sell
2,724
-835
-23% -$430K 1.24% 21
2023
Q2
$1.75M Buy
3,559
+305
+9% +$128K 1.1% 21
2023
Q1
$1.19M Buy
+3,254
New +$1.1M 0.79% 32

Other funds holding LLY

Imprint Wealth's LLY Position: Q1 2026 in Review

Imprint Wealth reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $18.2K and leaving 88 shares worth $80.9K. The position accounts for 0.37% of the portfolio, ranked #47.

Imprint Wealth first reported a position in LLY in Q1 2023 and has held it in 8 quarters since. The position peaked at $3.25M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Imprint Wealth held 88 shares of Eli Lilly worth $80.9K as of Q1 2026.
  • Imprint Wealth sold 18 Eli Lilly shares in Q1 2026, an estimated $18.2K.
  • Eli Lilly made up 0.37% of Imprint Wealth's portfolio in Q1 2026, its #47 holding.
  • Imprint Wealth first reported a position in Eli Lilly in Q1 2023 and has held it in 8 quarters since.
  • Imprint Wealth's Eli Lilly position peaked at $3.25M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.